why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: March 25, 2025

Clinical Trial: A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Mild Hypertension

Study Type: INTERVENTIONAL


Official Title: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered QCZ484

Brief Summary: This is a randomized, double-blind, placebo-controlled study including Part A single ascending dose (SAD) in healthy subjects and Part B single dose in subjects with mild hypertension.

Read more